# Ne oldu?

Medline has issued a correction for convenience kits containing BD ChloraPrep applicators due to potential sterility compromise from packaging defects. The FDA classifies this as a device correction, not a removal. Affected users must remove and discard the applicators and apply over-labels to kits.

# Ayrıntılar

The correction involves specific lots of the BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators. Packaging defects include wrinkles in the paper lidding that may extend to the seal area or incomplete seals on the applicator packaging. These defects may compromise the sterile barrier, potentially exposing patients and users to microbial contamination.

Medline sent letters to affected customers on June 12 and July 20 recommending immediate stock checks, quarantine, and application of provided over-labels. The over-labels state that the affected components must be removed and discarded prior to use. Other components within the convenience kits may still be used.

The FDA has determined that this device may cause temporary or reversible health problems, or though unlikely, serious health problems. This correction involves correcting certain devices and does not involve removing them from where they are used or sold.

# Neden önemli?

This correction is important because it affects medical procedures that rely on sterile applicators. If the sterile barrier is compromised, patients may be exposed to microbial contamination. Potential health consequences range from no injury to localized infection, or less commonly, serious infection requiring medical treatment and antimicrobial therapy. Healthcare facilities must check their stock and ensure the affected applicators are removed and labeled to prevent patient exposure.

# Sırada ne var?

Medline and the FDA are monitoring the situation. Affected users should continue to check for updates and follow the recommended corrective actions of removing and discarding the applicators and applying over-labels to kits.